Germany Healthcare Outlook Report 2023 | Major companies: Fresenius AG, Bayer AG, Evotec AG, Boehringer Ingelheim, Merck KGaA, Helios Kliniken GmbH, Sandoz International GmbH, Symrise AG, Alexianer GmbH, TÜV NORD Group

DelveInsight's "Germany Healthcare Outlook Report, 2023," report provides comprehensive insights into the healthcare scenario, regulatory policies, and reimbursement landscape in Germany. The report also identifies key trends in the healthcare market and provides insights into the demographic and healthcare infrastructure of the country. Along with this the report also provides a brief look into the trends and segmentation of the pharmaceutical and medical devices market in Germany.

According to DelveInsight's analysis, Germany is home to well-established medical device manufacturers, with several global key players also having a presence in the country. Despite this, the majority of the industry is small- to mid-sized medical device companies. Germany stands out as an appealing market, driven by its sustained growth and advanced healthcare practices. The demand for cutting-edge technologies, as well as diagnostic, therapeutic, and minimally invasive equipment, continues to be substantial. With many German manufacturers exporting their products, there exists an opportunity for foreign importers to tap into these high demands.

Learn more about key trends in the Germany Healthcare Market @ https://www.delveinsight.com/report-store/germany-healthcare-outlook-report?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Germany Healthcare Outlook

Germany, officially known as the Federal Republic of Germany, is situated in Central and Western Europe and has a population of 83.2 million people spread across a territory covering 357,022 square kilometers. In 2019, Germany experienced a GDP growth rate of 0.6%. The country operates a comprehensive multi-payer healthcare system that caters to both statutory health insurance for individuals with incomes below a specific threshold and private health insurance for those with higher incomes who opt to procure their own coverage.

The healthcare system consists of two main subsystems: statutory health insurance (SHI) and private health insurance. SHI includes competing, not-for-profit, non-governmental health insurance plans referred to as sickness funds. Additionally, private health insurance options are available. Long-term care services are managed separately through Germany's mandatory statutory long-term care insurance (LTCI). Notably, healthcare providers, including hospitals and physicians, serve patients irrespective of whether they are covered by SHI or private insurance.

The financing of the German healthcare system is predominantly borne by employers and employees through premiums. Workers contribute approximately 7.5% of their salary to a public health insurance pool, with employers matching this 7.5% contribution. This principle of shared responsibility persists in the modern German system, ensuring that everyone covered by statutory insurance has equal access to medical care. The system also imposes strict limits on out-of-pocket costs, effectively minimizing the occurrence of unexpected medical expenses.

Germany Industry Overview Chapter

1. Pharmaceutical

The German pharmaceutical market is the largest in Europe and the fourth largest in the world. 1170 pharmaceutical and biotechnology companies with more than 128,000 workers (2015) operate in Germany. In addition to globally successful enterprises, the industry composed of more than 800 medium-sized businesses and young biotech companies. German companies invest $6.5 billion (2016) annually in research and development. Within Europe, Germany is the leading market for non-prescription medicines products.

2. Medical Device

The German medical device market is the largest in Europe and the third-largest in the world. It was valued at $26 billion in 2014 and continues to grow despite a sluggish European economy. Germany has become one of the world's most important countries for clinical studies. Germany is the leader in industry-initiated clinical studies in Europe and second worldwide. The dense network of universities and faculties as well as a variety of research institutions not affiliated to universities speak in favor of Germany as a business location.

Apart from this, the report covers some latest information on the COVID 19 update and the future of healthcare technology in Germany.

Learn how the Germany Healthcare market is growing in the Pharmaceutical and Medical Device sector @ https://www.delveinsight.com/report-store/germany-healthcare-outlook-report?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Germany Healthcare Outlook Report Highlights

1. Overview of the pharmaceutical and medical device markets

2. An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices

3. Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditure

4. An overview of the opportunities for and challenges to growth in the healthcare market

Request for a detailed sample report @ https://www.delveinsight.com/sample-request/germany-healthcare-outlook-report?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Germany Healthcare Outlook Key Players

Major key companies involved in the Germany Healthcare market are Fresenius AG, Bayer AG, Evotec AG, Boehringer Ingelheim, Merck KGaA, Helios Kliniken GmbH, Sandoz International GmbH, Symrise AG, Alexianer GmbH, TÜV NORD Group, and others.

Learn more about the key companies at:
https://www.delveinsight.com/report-store/germany-healthcare-outlook-report?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Table of contents

1. Key Insights

2. Germany at a Glance

3. Executive Summary

4. Assessment

5. Market Access

6. Germany PESTLE Analysis

7. Driver and Barriers

8. Appendix

9. References

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

Get the Detailed TOC of the Germany Healthcare Outlook Report here:
https://www.delveinsight.com/report-store/germany-healthcare-outlook-report?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Contact Us:

Kritika Rehani
info@delveinsight.com
+91-9650213330
www.delveinsight.com

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.